T2 Biosystems CS (TTOO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 1,964 | 2,078 | 5,483 | 3,677 | 5,911 |
| Cost of Goods | 4,869 | 3,995 | 3,639 | 6,085 | 5,081 |
| Gross Profit | -2,905 | -1,917 | 1,844 | -2,408 | 830 |
| Operating Expenses | 11,015 | 12,765 | 12,003 | 13,477 | 15,930 |
| Operating Income | -13,051 | -13,687 | -9,520 | -15,800 | -15,019 |
| Interest Expense | 1,541 | 1,522 | 1,528 | 1,560 | 1,346 |
| Other Income | 8,245 | -2,756 | 945 | -15 | -1,665 |
| Pre-tax Income | -6,347 | -17,965 | -10,103 | -17,375 | -18,030 |
| Net Income Continuous | -6,347 | -17,965 | -10,103 | -17,375 | -18,030 |
| Net Income | $-6,347 | $-17,965 | $-10,099 | $-17,375 | $-18,034 |
| EPS Basic Total Ops | -7.84 | -131.77 | 68.51 | -294.65 | -510.00 |
| EPS Basic Continuous Ops | -7.84 | -131.77 | 68.98 | -289.16 | -509.93 |
| EPS Diluted Total Ops | -7.84 | -131.77 | 68.51 | -294.65 | -510.00 |
| EPS Diluted Continuous Ops | -7.84 | -131.77 | 68.98 | -289.16 | -509.93 |
| EPS Diluted Before Non-Recurring Items | -8.00 | -117.00 | N/A | N/A | N/A |
| EBITDA(a) | $-12,784 | $-13,431 | $-9,265 | $-15,540 | $-14,773 |